These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23051943)

  • 1. Cryptogenic cirrhosis: metabolic liver disease due to insulin resistance.
    De BK; Mani S; Mandal SK; Mondal SS; Bhattacharya R; Pramanik AB; Sau D; Bhattacharjee K; Joardar S
    Indian J Med Sci; 2010 Nov; 64(11):508-19. PubMed ID: 23051943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of body fat distribution by waist circumference, dual-energy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women.
    dos Santos RE; Aldrighi JM; Lanz JR; Ferezin PC; Marone MM
    Gynecol Endocrinol; 2005 Nov; 21(5):295-301. PubMed ID: 16373250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THE CORRELATION OF NECK CIRCUMFERENCE AND INSULIN RESISTANCE IN NAFLD PATIENTS.
    Boemeke L; Raimundo FV; Bopp M; Leonhardt LR; Fernandes SA; Marroni CA
    Arq Gastroenterol; 2019; 56(1):28-33. PubMed ID: 31141077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
    Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
    Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis.
    Rinaldi L; Nascimbeni F; Giordano M; Masetti C; Guerrera B; Amelia A; Fascione MC; Ballestri S; Romagnoli D; Zampino R; Nevola R; Baldelli E; Iuliano N; Rosato V; Lonardo A; Adinolfi LE
    World J Gastroenterol; 2017 Feb; 23(8):1458-1468. PubMed ID: 28293093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
    Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
    J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?
    Fu JF; Shi HB; Liu LR; Jiang P; Liang L; Wang CL; Liu XY
    World J Gastroenterol; 2011 Feb; 17(6):735-42. PubMed ID: 21390143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Cell dysfunction is associated with metabolic syndrome severity in adults.
    Malin SK; Finnegan S; Fealy CE; Filion J; Rocco MB; Kirwan JP
    Metab Syndr Relat Disord; 2014 Mar; 12(2):79-85. PubMed ID: 24283920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in obese children and adolescents.
    Romualdo MC; Nóbrega FJ; Escrivão MA
    J Pediatr (Rio J); 2014; 90(6):600-7. PubMed ID: 25019650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
    Fujii H; Imajo K; Yoneda M; Nakahara T; Hyogo H; Takahashi H; Hara T; Tanaka S; Sumida Y; Eguchi Y; Chayama K; Nakajima A; Nishimoto N; Kawada N;
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1390-1395. PubMed ID: 30600551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths.
    Kelishadi R; Cook SR; Amra B; Adibi A
    Atherosclerosis; 2009 Jun; 204(2):538-43. PubMed ID: 19013572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of chronic viral hepatitis B with insulin resistance.
    Lee JG; Lee S; Kim YJ; Cho BM; Park JS; Kim HH; Cheong J; Jeong DW; Lee YH; Cho YH; Bae MJ; Choi EJ
    World J Gastroenterol; 2012 Nov; 18(42):6120-6. PubMed ID: 23155341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients.
    Hu Y; Liu J; Dong X; Xu Y; Leng S; Wang G
    Med Sci Monit; 2016 Nov; 22():4146-4151. PubMed ID: 27803497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.
    Park SH; Kim BI; Kim SH; Kim HJ; Park DI; Cho YK; Sung IK; Sohn CI; Kim H; Keum DK; Kim HD; Park JH; Kang JH; Jeon WK
    J Am Coll Nutr; 2007 Aug; 26(4):321-6. PubMed ID: 17906183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.
    Campanati A; Ganzetti G; Di Sario A; Damiani A; Sandroni L; Rosa L; Benedetti A; Offidani A
    J Gastroenterol; 2013 Jul; 48(7):839-46. PubMed ID: 23065020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.